Welcome to the conclusion of this two part series on the newest hot topics in melanoma research.
In Tanorexia? The Latest Skinny on Melanoma, we debunked myths about who is at risk and addressed means of prevention along with rare, devastating forms.
I enlisted the help of three leading melanoma researchers from The Wistar Institute —our nation’s first independent biomedical research facility where I am a member of the leadership council. Today, we focus on immunotherapy and the new frontier in the field of melanoma research and treatments.
Let’s continue the conversation with ...